Summary
Updated Aug 31, 2026
Latha Vairavan is SVP Chief Financial Officer of Arcutis Biotherapeutics, Inc. (ARQT). 6 SEC Form 4 filings on record going back to 2025, most recently on 13 May 2026. Most recent open-market trade: sold $9K of ARQT on 13 May 2026. Lifetime open-market sales: $150K.
Recent Transactions
8Every recent SEC Form 4 transaction Latha Vairavan has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Latha Vairavan go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. 8 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Latha Vairavan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd Watanabe - $5.50M of ARQT open-market activity in the last 12 months
- Masaru Matsuda - $2.45M of ARQT open-market activity in the last 12 months
- Howard G. Welgus - $2.18M of ARQT open-market activity in the last 12 months
- Patrick Burnett - $1.56M of ARQT open-market activity in the last 12 months
- Keith R. Leonard - $997K of ARQT open-market activity in the last 12 months
- Terrie Curran - $984K of ARQT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Latha Vairavan?
Latha Vairavan is a corporate insider, tracked as SVP Chief Financial Officer of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Latha Vairavan last file a Form 4?
The most recent primary Form 4 on record is dated 13 May 2026, one of 6 filings going back to 2025.
Has Latha Vairavan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($150K) across all tracked filings.
Where can I see all of Latha Vairavan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Latha Vairavan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial